Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Operating activities
Net income	$ 18,483	$ 8,476
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,241	5,047
Deferred income taxes	5,485	3,561
Provision for credit losses, doubtful accounts receivable, and reserve for settlement assets	1,002	759
Stock-based compensation	912	771
Other	692	2,425
Changes in assets and liabilities:
Trade accounts receivable	(200)	(4,572)
Settlement assets, disbursement prefunding, prepaid expenses, other current assets, and other assets	(20,380)	8,250
Trade accounts payable, accrued expenses, settlement liabilities, other current liabilities, and other liabilities	(12,771)	(6,285)
Customer funds deposits	2,810	(3,017)
Deferred revenue	(1,110)	(540)
Net cash provided by operating activities	164	14,875
Investing activities
Capital expenditures	(5,278)	(4,322)
Purchase of convertible preferred stock in equity method investment	(673)	(672)
Purchases of debt securities and equity investments	(12,669)	(7,750)
Proceeds from maturities and sales of debt securities and redemption of equity investments	9,878	17,067
Net cash (used in) provided by investing activities	(8,742)	4,323
Financing activities
Dividends paid	(1,261)
Distributions to noncontrolling interests		(55)
Proceeds from borrowings under revolving credit facility	14,243	30,315
Repayment of borrowings under revolving credit facility	(14,243)	(30,315)
Proceeds from exercise of stock options		172
Repurchases of Class B common stock	(2,432)	(2,851)
Net cash used in financing activities	(3,693)	(2,734)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash and cash equivalents	28	(6,834)
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents	(12,243)	9,630
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	255,456	198,823
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	243,213	208,453
Supplemental Schedule of Non-Cash Financing Activities
Shares of the Company’s Class B common stock issued to an executive officer for bonus payment	$ 1,824